Bayer said its takeover offer for Norwegian cancer drug maker Algeta was successful, allowing the German firm to go forward with the $2.6 billion deal to strengthen its oncology business.
via WSJ.com: US Business http://ift.tt/1kfBUtU
via WSJ.com: US Business http://ift.tt/1kfBUtU
Nessun commento:
Posta un commento